Evonik commissions advanced biomaterials production facility in Birmingham
The adjacent CDMO site, which has been successfully inspected by U.S.-FDA and E.U.-health authorities, also offers a range of formulation development and GMP manufacturing services for parenteral drug products, and application development and scale-up services for implantable medical devices.
.jpg)
.jpg)





























